CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 219 enrolled
Drug / intervention
Minitouch Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04267562
NCT04267562N/ACompleted
CompareCT.gov

Minitouch Endometrial Ablation System Treatment for Menorrhagia: An Evaluation of Safety & Effectiveness (EASE Clinical Trial)

MicroCube, LLC·interventional·Posted Feb 13, 2020·Updated Nov 18, 2024

In Brief

A clinical study evaluating Minitouch System for Menorrhagia and 2 related conditions. Completed, enrolled 219 participants across 5 sites.

Detailed Summary

The EASE Clinical Trial is prospective, multi-center, single-arm (open-label), non-randomized, clinical trial to evaluate the Minitouch Endometrial Ablation System ("Minitouch System") in premenopausal women with menorrhagia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenorrhagia, Heavy Menstrual Bleeding, Heavy Uterine Bleeding
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 13, 2020
Enrollment StartFeb 28, 2020
Primary CompletionJul 20, 2022
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 6.4 years ago

Interventions

Minitouch Systemdevice

The investigational treatment (endometrial ablation) will be performed utilizing the Minitouch System